218 related articles for article (PubMed ID: 17121496)
1. Gout in 2006: the perfect storm.
Terkeltaub R
Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
[TBL] [Abstract][Full Text] [Related]
2. [Hyperuricemia and gout: therapeutic indications].
Pawlotsky Y
Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of gout.
Pittman JR; Bross MH
Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
[TBL] [Abstract][Full Text] [Related]
4. Pipeline Therapies for Gout.
Yip K; Braverman G; Yue L; Fields T
Curr Rheumatol Rep; 2024 Mar; 26(3):69-80. PubMed ID: 38133712
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
Terkeltaub R; Bushinsky DA; Becker MA
Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043
[TBL] [Abstract][Full Text] [Related]
6. [Current treatment of hyperuricemia and gout].
Vukotić D
Med Pregl; 1982; 35(5-6):213-7. PubMed ID: 7177063
[No Abstract] [Full Text] [Related]
7. The management of gout: it should be crystal clear.
Wortmann RL
J Rheumatol; 2006 Oct; 33(10):1921-2. PubMed ID: 17014007
[No Abstract] [Full Text] [Related]
8. New developments in clinically relevant mechanisms and treatment of hyperuricemia.
Lee SJ; Terkeltaub RA
Curr Rheumatol Rep; 2006 Jun; 8(3):224-30. PubMed ID: 16901081
[TBL] [Abstract][Full Text] [Related]
9. Renal urate transport.
Mount DB; Kwon CY; Zandi-Nejad K
Rheum Dis Clin North Am; 2006 May; 32(2):313-31, vi. PubMed ID: 16716882
[TBL] [Abstract][Full Text] [Related]
10. [Choice between uricosurics and inhibitors of uric acid synthesis in the treatment of gout].
Kono H; Yonezawa H; Naito H
Nihon Rinsho; 1975 Feb; 33(2):356-60. PubMed ID: 1170378
[No Abstract] [Full Text] [Related]
11. Understanding treatments for gout.
Cannella AC; Mikuls TR
Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
[TBL] [Abstract][Full Text] [Related]
12. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
Darmawan J; Rasker JJ; Nuralim H
J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
[TBL] [Abstract][Full Text] [Related]
13. Control of crystal-induced arthropathies.
Diamond HS
Rheum Dis Clin North Am; 1989 Aug; 15(3):557-67. PubMed ID: 2672137
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors.
Ishibuchi S; Morimoto H; Oe T; Ikebe T; Inoue H; Fukunari A; Kamezawa M; Yamada I; Naka Y
Bioorg Med Chem Lett; 2001 Apr; 11(7):879-82. PubMed ID: 11294382
[TBL] [Abstract][Full Text] [Related]
15. [Gout as an unusual cause of pelvic pain].
van den Berge M; Vrugt B; Holt C; Smit CJ; Hoogenberg K
Ned Tijdschr Geneeskd; 2006 Jan; 150(3):151-4. PubMed ID: 16463619
[TBL] [Abstract][Full Text] [Related]
16. [Uric acid and its metabolism].
Kissel P; Royer R
Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
[No Abstract] [Full Text] [Related]
17. Treatment of hyperuricaemia and gout.
Roddy E; Doherty M
Clin Med (Lond); 2013 Aug; 13(4):400-3. PubMed ID: 23908515
[No Abstract] [Full Text] [Related]
18. Crystal-induced arthropathies: recent investigative advances.
Ellman MH; Becker MA
Curr Opin Rheumatol; 2006 May; 18(3):249-55. PubMed ID: 16582687
[TBL] [Abstract][Full Text] [Related]
19. New drugs for crystal deposition diseases.
McCarthy G
Curr Opin Rheumatol; 2006 Mar; 18(2):170. PubMed ID: 16462523
[No Abstract] [Full Text] [Related]
20. Agents for the Treatment of Gout: Current Advances and Future Perspectives.
Zeng X; Liu Y; Fan Y; Wu D; Meng Y; Qin M
J Med Chem; 2023 Nov; 66(21):14474-14493. PubMed ID: 37908076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
